WallStreetZenWallStreetZen

NASDAQ: FDMT
4d Molecular Therapeutics Inc Stock Ownership - Who owns 4d Molecular Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have 4d Molecular Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David KirnPresident and Chief Executive Officer2026-07-10442$12.84
$5.67kSell
David KirnPresident and Chief Executive Officer2026-07-1015,283$12.01
$183.56kSell
David KirnPresident and Chief Executive Officer2026-07-0942,608$12.87
$548.19kSell
Scott BizilyChief Legal Officer2026-06-306,566$14.00
$91.92kSell
Scott BizilyChief Legal Officer2026-06-30814$4.14
$3.37kBuy
Scott BizilyChief Legal Officer2026-06-305,752$6.49
$37.33kBuy
Scott BizilyChief Legal Officer2026-06-239,810$12.00
$117.72kSell
Scott BizilyChief Legal Officer2026-06-239,810$4.14
$40.61kBuy
David KirnPresident and Chief Executive Officer2026-06-22114,746$10.47
$1.20MSell
David KirnPresident and Chief Executive Officer2026-06-011,922$10.02
$19.26kSell

1 of 3

FDMT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FDMT insiders and whales buy or sell their stock.

FDMT Shareholders

What type of owners hold 4d Molecular Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Janus Henderson Group PLC10.04%5,247,151$57.67MInstitution
Ra Capital Management LP9.66%5,049,779$55.50MInstitution
Ra Capital Management LP8.73%4,563,211$50.15MInsider
Viking Global Investors LP8.13%4,247,914$46.68MInsider
Goldman Sachs Group Inc 18.04%4,205,438$46.22MInstitution
Blackrock Inc7.93%4,145,303$45.56MInstitution
Novo Holdings A6.98%3,650,737$40.12MInstitution
Bvf Inc5.51%2,879,289$31.64MInstitution
State Street Corp5.18%2,707,875$29.76MInstitution
Vanguard Capital Management LLC4.20%2,195,578$24.13MInstitution

1 of 3

FDMT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FDMT80.12%19.88%Net SellingNet Selling
AGMB47.92%0.09%
GYRE2.05%97.95%Net SellingNet Selling
NGNE48.67%51.33%Net SellingNet Selling
TECX26.26%73.74%Net BuyingNet Selling
View Top Biotech Stocks

4d Molecular Therapeutics Stock Ownership FAQ

Who owns 4d Molecular Therapeutics?

4d Molecular Therapeutics (NASDAQ: FDMT) is owned by 96.83% institutional shareholders, 24.03% 4d Molecular Therapeutics insiders, and 0.00% retail investors. Ra Capital Management LP is the largest individual 4d Molecular Therapeutics shareholder, owning 4.56M shares representing 8.73% of the company. Ra Capital Management LP's 4d Molecular Therapeutics shares are currently valued at $50.61M.

If you're new to stock investing, here's how to buy 4d Molecular Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.